Valproate Therapy

Epilepsy Management

• The American Academy of Neurology recommends valproate as an alternative to phenytoin for refractory status epilepticus, with potentially fewer adverse effects and comparable efficacy 1, 2

Psychiatric Indications

• The American Psychiatric Association recommends valproate for acute treatment of bipolar mania and maintenance treatment of bipolar disorder, with treatment recommended for at least 2 years after the last episode 3
• The American Academy of Child and Adolescent Psychiatry suggests that combination therapy with valproate and antipsychotics may provide enhanced efficacy for bipolar disorder 6, 7

Special Populations

• Women with epilepsy require careful monitoring due to potential reproductive endocrine effects, including menstrual irregularities, polycystic ovaries, and hyperandrogenism, which may be related to weight gain and insulin sensitivity changes 4, 5